Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
1990-2-22
|
pubmed:language |
fre
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0003-410X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
140
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
647
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2692496-Adult,
pubmed-meshheading:2692496-Anticoagulants,
pubmed-meshheading:2692496-Clinical Trials as Topic,
pubmed-meshheading:2692496-Drug Evaluation,
pubmed-meshheading:2692496-Female,
pubmed-meshheading:2692496-Heparin,
pubmed-meshheading:2692496-Humans,
pubmed-meshheading:2692496-Male,
pubmed-meshheading:2692496-Paraplegia,
pubmed-meshheading:2692496-Thrombophlebitis
|
pubmed:year |
1989
|
pubmed:articleTitle |
[Prevention of venous thrombosis in paraplegic patients. An open study of fraxiparin].
|
pubmed:publicationType |
Letter,
Clinical Trial
|